Skip to main content
SpringerLink
Log in

Human T-cell leukemia virus type II infection among high risk groups and its influence on HIV-1 disease progression

  • Published:
European Journal of Epidemiology Aims and scope Submit manuscript

Abstract

The prevalence and the risk factors of the human T-cell leukemia virus type I/II (HTLV-I/II) infection were evaluated among 552 individuals at high risk for HIV-1. HTLV infections showed a low (1.6%) prevalence, were restricted to intravenous drug addicts and were due to HTLV-II alone. Moreover, in order to weigh the influence of HTLV-II on the natural history of HIV-1 infection, the clinical outcome of HIV-1 disease was compared between subjects with and without HTLV-II coinfection. Our findings showed that HTLV-II does not adversely affect the outcome of HIV-1 infection. Infact, a slower disease progression has been recorded in some HTLV-II coinfected subjects.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Lairmore MD, Jacobson S, Garcia F, et al. Isolation of human T-lymphotropic virus type 2 from Guayami Indians in Panama. Proc Natl Acad Sci USA 1990; 87: 8840–8844.

    Google Scholar 

  2. Maloney BM, Biggar RJ, Neel JV, et al. Endemic human T-cell lymphotropic virus type II infection among isolated Brazilian Amerindians. J Infect Dis 1992; 166: 100–107.

    Google Scholar 

  3. Lee H, Swanson P, Shorty VS, et al. High rate of HTLV-II infection in seropositive IV drug abusers in New Orleans. Science 1989; 224: 471–475.

    Google Scholar 

  4. Kwok S, Gallo D, Hanson C, et al. High prevalence of HTLV-II among intravenous drug abusers: PCR confirmation and typing. AIDS Res Hum Retrovir 1990; 6: 561–565.

    Google Scholar 

  5. Khabbaz RF, Onorato IM, Cannon RO, et al. Seroprevalence of HTLV-I and HTLV-II among intravenous drug users and persons in clinics for sexually transmitted diseases. N Engl J Med 1992; 326: 375–380.

    Google Scholar 

  6. Zella D, Mori L, Sala M, et al. HTLV-II infection in Italian drug abusers. Lancet 1990 (ii): 575–576.

  7. Varnier OE, Alexander SS, Forbis RM, et al. HTLV seroactivity in Italian intravenous drug addicts is primarily due to HTLV-II infection. J Am Med Ass 1991; 265: 597.

    Google Scholar 

  8. De Rossi A, Mammano F, De Mistro A, et al. Serological and molecular evidence of infection by human T-cell lymphotropic virus type II in Italian drug addicts by use of syntetic peptides and polymerase chain reaction. Eur J Cancer 1991; 27: 835–838.

    Google Scholar 

  9. Zanetti AR, Galli C. Seroprevalence of HTLV-I and HTLV-II. N Engl J Med 1992; 326: 1783–1784.

    Google Scholar 

  10. Zanetti AR, Zehender G, Tanzi E, et al. HTLV-II among Italian intravenous drug users and hemophiliacs. Eur J Epidemiol 1992; 8: 702–707.

    Google Scholar 

  11. Calabró ML, Luparello M, Grottola A, et al. Detection of human T-lymphotropic virus type IIb in human immunodeficiency virus type 1-coinfected persons in southeastern Italy. J Infect Dis 1993; 168: 1273–1277.

    Google Scholar 

  12. Visconti A, Visconti L, Bellocco R, et al. HTLV-II/HIV-1 coinfection and risk for progression to AIDS among intravenous drug users. J Acquir Immune Defic Syndr 1993; 6: 1228–1237.

    Google Scholar 

  13. Soriano V, Pillonel J, Wicks R, et al. HTLV-I and HTLV-II in Western Europe. 6th International Conference on Human Retrovirology: HTLV Absecon, USA, May 14–19, 1994 (Abstract E 140).

  14. Kalyanaram VS, Sarngadharan MG, Robert-Guroff M, et al. A new subtype of human T-cell leukemia virus (HTLV-II) associated with a variant of hairy cell leukemia. Science 1982; 218: 571–573.

    Google Scholar 

  15. Rosenblatt JD, Golde DW, Wachsman W, et al. A second isolated of HTLV-II associated with a variant of hairy cell leukemia. N Eng J Med 1986; 315: 372–377.

    Google Scholar 

  16. Loughran Jr RP, Coyle T, Sherman MP, et al. Detection of human T-cell leukemia/lymphoma virus, type II, in a patient with large granular lymphocytic leukemia. Blood 1992; 80: 1116–1119.

    Google Scholar 

  17. Hjelle B, Appenzeller O, Mills R, et al. Chronic neurodegenerative disease associated with HTLV-II infection. Lancet 1992; 339: 645–646.

    Google Scholar 

  18. Berger JR, Avenningsson A, Raffanti S, et al. Tropical spastic paraparesis-like illness occurring in a patient dually infected with HIV-1 and HTLV-II. Neurology 1991; 41: 85–87.

    Google Scholar 

  19. Murphy EL, Engstrom JW, Miller K, et al. HTLV-II associated myelopathy in a 43 year old woman. Lancet 1993; 341: 757–758.

    Google Scholar 

  20. Kaplan MH, Hall WW, Susin M, et al. Syndrome of severe skin disease, eosinophilia and dermatopathic lymphadenopathy in patients with HTLV-II complicating human immunodeficiency virus infections. Am J Med 1991; 91: 300–309.

    Google Scholar 

  21. Weiss SH, Klein C, French J, et al. Mortality associated with human T-cell lymphotropic virus type 2 (HTLV-2) infection in intravenous drug abusers. Presented at the 7th International Conference on AIDS. Florence, June 1991 (Abstract TH. C. 1001).

  22. Page JB, Lai SH, Chitwood DD, et al. HTLV-I/II seropositivity and death from AIDS among HIV-1 seropositive intravenous drug users. Lancet 1990; 335: 1439–1441.

    Google Scholar 

  23. Hershow RC, Fukuda K, Graber J, et al. Does HTLV-II coinfection predict clinical progression in HIV-infected drug users? Presented at the 10th International Conference on AIDS. Yokoama, August 1994 (Abstract PC 0210).

  24. Centers for Disease Control: Classification system for human T-lymphotropic virus type III/lymphadenopathy-associated virus infections. MMWR 1986; 35: 334–339.

    Google Scholar 

  25. Morb Mortal Wkly Rep. Licensure of screening tests for antibodies to human T-lymphotropic virus type I. 1988; 37: 736–740, 745–747.

  26. Centers for Disease Control. Guidelines for counseling persons infected with Human T-Lymphotropic Virus Type I (HTLV-I) and Type II (HTLV-II). Ann Intern Med 1993; 118: 448–454.

    Google Scholar 

  27. Krook A, Blomberg J. HTLV-II among injecting drug users in Stockholm. Scand J Infect Dis 1994; 26: 129–132.

    Google Scholar 

  28. Rosenberg ZF, Fauci AS. Immunopathogenesis of HIV infection. FASEB 1991; 5: 2382–2390.

    Google Scholar 

  29. Bartholomew C, Blatter W, Cleghorn F. Progression to AIDS in homosexual men co-infected with HIV and HTLV_I in Trinidad. Lancet 1987 (ii): 1469.

  30. Lefrere HH, Courouce AM, Mariotti M, et al Rapid progression to AIDS in dual HIV/HTLV-I infection. Lancet 1990; 336: 509.

    Google Scholar 

  31. Böhnlein E, Siekevitz M, Ballard DW, et al. Stimulation of HIV-1 enhancer by HTLV-I tax gene product involves the action of inducible cellular proteins. J Virol 1989; 63: 1578–1786.

    Google Scholar 

  32. Zack JA, Caan AJ, Lugo JD, et al. HIV-1 production from peripheral blood cells after HTLV-I induced mitogenic stimulation. Science 1988; 240: 1026–1029.

    Google Scholar 

  33. Lusso P, Lori F, Gallo RC. CD4-indipendent infection by human immunodeficiency virus type 1 after phenotypic mixing with human T-cell leukemia viruses. J Virol 1990; 64: 6341–6344.

    Google Scholar 

  34. Richardson JH, Edwards AJ, Cruickshannk JK, et al. In vivo cellular tropism of human T-cell leukemia virus type 1. J Virol 1990; 64: 5682–5687.

    Google Scholar 

  35. Ijichi S, Ramundo MB, Takahashi H, et al. In vivo cellular tropism of human T-cell leukemia virus type II (HTLV-II). J Exp Med 1992; 176: 293–296.

    Google Scholar 

  36. Casoli C, Cimarelli A, Bertazzoni U. Cellular tropism of human T-cell leukemia virus type II is enlarged to B lymphocites in patients with high proviral load. Virology 1995; 206: 1126–1128.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Cattedra di Malattie Infettive dell' Universià di Parma, via Gramsci 14, I-43100, Parma, Italy

    Magnani Giacomo, Elia Gian Franco, Calzetti Carlo, Degli Antoni Anna & Fiaccadori Franco

  2. Istituto di Patologia Medica, Università degli Studi di Parma, Italy

    Casoli Claudio & Donatini Anna

Authors
  1. Magnani Giacomo
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Elia Gian Franco
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Casoli Claudio
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Calzetti Carlo
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Degli Antoni Anna
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Donatini Anna
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Fiaccadori Franco
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Giacomo, M., Franco, E.G., Claudio, C. et al. Human T-cell leukemia virus type II infection among high risk groups and its influence on HIV-1 disease progression. Eur J Epidemiol 11, 527–533 (1995). https://doi.org/10.1007/BF01719304

Download citation

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01719304

Key words

Search

Navigation